Submitted by Anonymous (not verified) on 7 October 2025 - 14:00
Human medicines European public assessment report (EPAR): Daxas, roflumilast, Date of authorisation: 05/07/2010, Revision: 22, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Daxas, roflumilast, Date of authorisation: 05/07/2010, Revision: 22, Status: Authorised